Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Salestools Logo

Salestools

#1 AI-agent för säljteam och Go-to-Market-team. Sälj mer, snabbare, med mindre ansträngning.

Produkt

  • AI-säljagenter
  • Intentionsdata
  • Teknologidata
  • Besöksspårning
  • Medpilot
  • Social Försäljning

Lösningar

  • Kundservice
  • E-handel
  • SaaS
  • Företag
  • Småföretag

Resurser

  • Rapporten
  • Dokumentation
  • API-referens
  • Hjälpcenter
  • Blogg
  • Fallstudier
  • Webbinarier

Företag

  • Om oss
  • Karriärer
  • Press
  • Kontakt
  • Partners

Våra kontor

  • New York, HQ
  • Bukarest, AI-forskningslabb
  • Zug, Schweiz

© 2026 Salestools. Alla rättigheter förbehållna.

Datavillkor och SäkerhetSekretesspolicyAnvändarvillkorAcceptable Use
Alla system fungerar
Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Back to Reports
Fundraising

Running Tide

Running Tide Raises $44M in Series Unknown

91 Hanover Street, Portland, ME 04101March 27, 20242 min read
Employees
80+

Running Tide Raises $44M in Series Unknown


Running Tide has successfully raised $44M in a Series Unknown at a $150M valuation led by Lowercarbon Capital, True Ventures, Shopify, Union Square Ventures.


Company Overview


Running Tide is a Climate Tech company headquartered in 91 Hanover Street, Portland, ME 04101, founded in 2017 with 80+ employees.


Ocean-based carbon removal


Fundraising Details


  • Amount Raised: $44M
  • Round Type: Series Unknown
  • Valuation: $150M
  • Date: 2024-03-27
  • Investors: Lowercarbon Capital, True Ventures, Shopify, Union Square Ventures

About Running Tide


Ocean-based carbon removal The company is positioned in the Climate Tech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 91 Hanover Street, Portland, ME 04101
  • Founded: 2017
  • Team Size: 80+
  • Industry: Climate Tech

What This Means


This funding round demonstrates strong investor confidence in Running Tide's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Climate Tech sector continues to attract significant investment as companies innovate to meet evolving market demands. Running Tide's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $150M valuation marks an important milestone for Running Tide, positioning the company among notable players in the Climate Tech industry.


Looking Ahead


With this new capital, Running Tide is well-positioned to execute on its growth strategy and continue building innovative solutions in the Climate Tech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-03-27. For more information about Running Tide, visit their headquarters at 91 Hanover Street, Portland, ME 04101.

Company Info

Headquarters
91 Hanover Street, Portland, ME 04101
Founded
2017
Team Size
80+

Topics

Fundraising(2912)Climate Tech(269)Series UnknownRunning Tide

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free